Born to Change
At AccuPulse, we are committed to bring revolutionary technology to treat cardiac arrhythmias with safer, faster and affordable solution for patients. Our innovation in pulsed field ablation and novel 3D electroanatomic mapping system will satisfy the unmet needs for change from patients and physicians who are fighting against Atrial Fibrillation and other cardiac arrhythmia diseases.
Company Profile
The mission of Accupulse is to treat atrial fibrillation (AF) and bring back better life to patients.
Nowadays, AF is a global epidemic with worldwide 33million people suffering from it. Cardiac catheter ablation is the major interventional therapy using Radio Frequency (RF) or Cryo as the most common sources of energy. However, both RF and Cryo have limitations in acute safety outcomes and the long term clinical results due to their thermal nature.
To satisfy these unmet clinical needs, AccuPulse is developing novel pulsed electric field ablation (PFA) generator and catheters, guided by a novel 3D mapping navigation system with better catheter localization, signal acquisition and more intelligent intergation.
News Center
